The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Palonosetron Accord 250mcg Solution for Injection – EU/1/16/1104/001
- Tadalafil Krka 10mg Film Coated Tablet – PA1347/071/003
Update on Supply of Adrenaline Auto-Injectors – 23 October 2018
The HPRA is aware of the global intermittent supply of adrenaline auto-injectors (AAIs) that impacts the Irish market. We have been working closely with all suppliers of AAIs to reduce the impact of supply disruptions on patients and healthcare professionals. While there are limited supplies of some specific AAIs, alternative AAIs are available.
We are also aware of possible difficulties that some pharmacists and patients may currently be experiencing in sourcing a 150mcg strength AAI. We have worked with the suppliers and additional stock of the 150mcg strength is due to be delivered to Ireland next week and again at the beginning of November. We will continue to closely monitor the supply situation.
The HPRA advises that patients and their carers familiarise themselves with the AAI that has been supplied as it may not have been one you have received previously. If you have any questions relating to administration of the auto-injector, please speak to your pharmacist or doctor.
The HPRA will be maintaining regular contact with all AAI suppliers and other relevant stakeholders. The medicine shortages list will be updated frequently as new information arrives and will provide information in relation to shortages of any individual medicines.
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated in real time.